Mifepristone Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 3 pharmaceutical companies such as CORCEPT THERAP, GENBIOPRO, TEVA PHARMS USA INC. It is marketed under 2 brand names, including KORLYM, MIFEPRISTONE. Available in 2 different strengths, such as 300MG, 200MG, and administered through 1 route including TABLET;ORAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 3 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"95468","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"b939b87c953c40af9333","publication_number":"US8921348B2","cleaned_patent_number":"8921348","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-08-27","publication_date":"2014-12-30","legal_status":"Granted"} US8921348B2 30 Dec, 2014 Granted 27 Aug, 2028
{"application_id":"95488","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"e381805fb9b14b309bd7","publication_number":"US10842801B2","cleaned_patent_number":"10842801","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-11-15","publication_date":"2020-11-24","legal_status":"Granted"} US10842801B2 24 Nov, 2020 Granted 15 Nov, 2032
{"application_id":"95487","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"e381805fb9b14b309bd7","publication_number":"US10500216B2","cleaned_patent_number":"10500216","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-03-05","publication_date":"2019-12-10","legal_status":"Granted"} US10500216B2 10 Dec, 2019 Granted 05 Mar, 2033
{"application_id":"95450","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"3b9b01bf3698437fbffa","publication_number":"US9943526B2","cleaned_patent_number":"9943526","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-20","publication_date":"2018-04-17","legal_status":"Granted"} US9943526B2 17 Apr, 2018 Granted 20 Apr, 2036
{"application_id":"95451","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"3b9b01bf3698437fbffa","publication_number":"US10166242B2","cleaned_patent_number":"10166242","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-20","publication_date":"2019-01-01","legal_status":"Granted"} US10166242B2 01 Jan, 2019 Granted 20 Apr, 2036
{"application_id":"95449","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"3b9b01bf3698437fbffa","publication_number":"US10166243B1","cleaned_patent_number":"10166243","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-20","publication_date":"2019-01-01","legal_status":"Granted"} US10166243B2 01 Jan, 2019 Granted 20 Apr, 2036
{"application_id":"95452","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"3b9b01bf3698437fbffa","publication_number":"US10660904B2","cleaned_patent_number":"10660904","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-20","publication_date":"2020-05-26","legal_status":"Granted"} US10660904B2 26 May, 2020 Granted 20 Apr, 2036
{"application_id":"95482","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"16dbe8ec8fbd4fcfa71a","publication_number":"US10495650B2","cleaned_patent_number":"10495650","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-08-12","publication_date":"2019-12-03","legal_status":"Granted"} US10495650B2 03 Dec, 2019 Granted 12 Aug, 2036
{"application_id":"95481","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"16dbe8ec8fbd4fcfa71a","publication_number":"US10006924B2","cleaned_patent_number":"10006924","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-08-12","publication_date":"2018-06-26","legal_status":"Granted"} US10006924B2 26 Jun, 2018 Granted 12 Aug, 2036
{"application_id":"95471","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"16dbe8ec8fbd4fcfa71a","publication_number":"US9829495B2","cleaned_patent_number":"9829495","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-08-15","publication_date":"2017-11-28","legal_status":"Granted"} US9829495B2 28 Nov, 2017 Granted 15 Aug, 2036
{"application_id":"95455","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"e9c68304fa7e4393b8a7","publication_number":"US10151763B2","cleaned_patent_number":"10151763","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-01-18","publication_date":"2018-12-11","legal_status":"Granted"} US10151763B2 11 Dec, 2018 Granted 18 Jan, 2037
{"application_id":"95499","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"881d63f2d2734b27bdab","publication_number":"US10195214B2","cleaned_patent_number":"10195214","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-06-19","publication_date":"2019-02-05","legal_status":"Granted"} US10195214B2 05 Feb, 2019 Granted 19 Jun, 2037
{"application_id":"95509","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"881d63f2d2734b27bdab","publication_number":"US10842800B2","cleaned_patent_number":"10842800","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-06-19","publication_date":"2020-11-24","legal_status":"Granted"} US10842800B2 24 Nov, 2020 Granted 19 Jun, 2037
{"application_id":"95512","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"881d63f2d2734b27bdab","publication_number":"US11969435B2","cleaned_patent_number":"11969435","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-06-19","publication_date":"2024-04-30","legal_status":"Granted"} US11969435B2 30 Apr, 2024 Granted 19 Jun, 2037
{"application_id":"130730","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"","publication_number":"US12097210B2","cleaned_patent_number":"12097210","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-06-19","publication_date":"2024-09-24","legal_status":"Granted"} US12097210B2 24 Sep, 2024 Granted 19 Jun, 2037
{"application_id":"95494","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"13046d7f66454af280ed","publication_number":"US10780097B2","cleaned_patent_number":"10780097","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-08-22","publication_date":"2020-09-22","legal_status":"Granted"} US10780097B2 22 Sep, 2020 Granted 22 Aug, 2038
{"application_id":"95492","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"13046d7f66454af280ed","publication_number":"US10231983B1","cleaned_patent_number":"10231983","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-08-22","publication_date":"2019-03-19","legal_status":"Granted"} US10231983B2 19 Mar, 2019 Granted 22 Aug, 2038
{"application_id":"95493","ingredient":"MIFEPRISTONE","trade_name":"KORLYM","family_id":"13046d7f66454af280ed","publication_number":"US10314850B1","cleaned_patent_number":"10314850","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-08-22","publication_date":"2019-06-11","legal_status":"Granted"} US10314850B2 11 Jun, 2019 Granted 22 Aug, 2038

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Mifepristone

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.